Multiple Sclerosis Fatigue
2 clinical trials · Condition
◉ Watch Multiple Sclerosis Fatigue
| Record | Firm | Date |
|---|---|---|
| Solriamfetol for the Treatment of Multiple Sclerosis Fatigue (NCT06170970) | Johns Hopkins University | 2024-06-01 |
| Ketamine for Multiple Sclerosis Fatigue (NCT05378100) | Johns Hopkins University | 2023-01-01 |
Track Multiple Sclerosis Fatigue automatically
Every clearance here is in the API, with alerts when new ones post.